Investors

Well-Financed with a Global Footprint

Adagene is a 21st century biotechnology company that is driving global innovation. Some of the world’s premier global venture funds have supported our growth. We have raised more than $150 million from private financings since 2014. The strong support from investors endorses our platform and strategy to develop differentiated immunotherapies.

F-Prime Capital
Eight Roads Ventures
WuXi AppTec
GP Capital Co., Ltd
Sequoia Capital
General Atlantic
New World TMT Ltd
greater bay area homeland investments limited